RIVA, Giovanni
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.447
EU - Europa 4.229
AS - Asia 1.387
Continente sconosciuto - Info sul continente non disponibili 14
SA - Sud America 12
AF - Africa 4
OC - Oceania 2
Totale 15.095
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.387
GB - Regno Unito 1.594
IT - Italia 890
SE - Svezia 592
CN - Cina 484
SG - Singapore 353
DE - Germania 303
HK - Hong Kong 215
UA - Ucraina 214
TR - Turchia 175
FI - Finlandia 169
FR - Francia 120
RU - Federazione Russa 93
BG - Bulgaria 88
IN - India 58
CA - Canada 42
BE - Belgio 37
ID - Indonesia 37
CZ - Repubblica Ceca 27
NL - Olanda 26
IR - Iran 18
BZ - Belize 15
IE - Irlanda 15
LT - Lituania 13
VN - Vietnam 13
EU - Europa 11
MY - Malesia 9
ES - Italia 6
JP - Giappone 6
RO - Romania 6
AT - Austria 5
GR - Grecia 5
PL - Polonia 5
SK - Slovacchia (Repubblica Slovacca) 5
CH - Svizzera 4
TW - Taiwan 4
CY - Cipro 3
KR - Corea 3
MX - Messico 3
PE - Perù 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AU - Australia 2
BD - Bangladesh 2
BR - Brasile 2
CL - Cile 2
CO - Colombia 2
SI - Slovenia 2
ZA - Sudafrica 2
A1 - Anonimo 1
AE - Emirati Arabi Uniti 1
AR - Argentina 1
BO - Bolivia 1
DK - Danimarca 1
EC - Ecuador 1
EE - Estonia 1
GN - Guinea 1
IL - Israele 1
IM - Isola di Man 1
IQ - Iraq 1
KH - Cambogia 1
KZ - Kazakistan 1
LU - Lussemburgo 1
LV - Lettonia 1
MA - Marocco 1
MD - Moldavia 1
MK - Macedonia 1
NO - Norvegia 1
PT - Portogallo 1
RS - Serbia 1
SY - Repubblica araba siriana 1
UZ - Uzbekistan 1
Totale 15.095
Salva come PNG Salva come JPEG
Città #
Southend 1.357
Fairfield 1.239
Santa Clara 996
Woodbridge 804
Ashburn 718
Chandler 636
Houston 578
Ann Arbor 507
Seattle 468
Jacksonville 425
Dearborn 423
Wilmington 417
Cambridge 389
Nyköping 350
Singapore 249
Hong Kong 212
Modena 179
Beijing 138
New York 120
Izmir 104
San Diego 97
Helsinki 93
Princeton 87
Sofia 85
Eugene 82
Fremont 75
Bremen 55
Milan 52
Moscow 42
Des Moines 40
London 40
Jakarta 37
Rome 37
Boardman 34
Brussels 33
Chicago 32
Redwood City 31
Munich 28
Ottawa 27
Bologna 24
San Jose 24
Shanghai 24
Dallas 18
Hefei 17
Washington 17
Belize City 15
Las Vegas 15
Naples 14
Toronto 14
Albuquerque 13
Nanjing 13
Paris 13
Philadelphia 13
Chiswick 12
Dong Ket 12
Dublin 12
Kunming 12
Norwalk 12
Tulare 12
Guangzhou 11
Reggio Emilia 10
Romainville 10
Saint Louis 10
San Francisco 10
Brno 9
Los Angeles 9
Palermo 9
Bangalore 8
Sacramento 8
Castelnuovo Di Porto 7
Columbus 7
Florence 7
Kilburn 7
Leawood 7
Pavia 7
Verona 7
Auburn Hills 6
Falls Church 6
Hounslow 6
Jinan 6
Nanchang 6
Saint Petersburg 6
San Mateo 6
Bari 5
Bengaluru 5
Castelnuovo Rangone 5
Changsha 5
Mountain View 5
Rimini 5
Andover 4
Baotou 4
Catania 4
Chongqing 4
Dongguan 4
Ferrara 4
Fuzhou 4
Genoa 4
Grafing 4
Groningen 4
Imola 4
Totale 11.881
Salva come PNG Salva come JPEG
Nome #
BCR-ABL-specific T-cell therapy in Ph+ ALL patients on tyrosine-kinase inhibitors 296
Characterization of Specific Immune Responses to Different Aspergillus Antigens during the Course of Invasive Aspergillosis in Hematologic Patients 283
Reversal of the glycolytic phenotype of primary effusion lymphoma cells by combined targeting of cellular metabolism and PI3K/Akt/ mTOR signaling 276
NPM1 mutations may reveal acute myeloid leukemia in cases otherwise morphologically diagnosed as myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms 258
Epidemiology and clinical outcome of lower respiratory tract infections by respiratory syncytial virus or parainfluenza virus type 3 in adults receiving treatment for either acute leukemia or severe aplastic anemia: a retrospective single center study 257
Detection of Fusarium-specific T cells in hematologic patients with invasive fusariosis 251
A case of JAK2 V617F-positive myelodysplastic/myeloproliferative neoplasm with unusual morphology, resembling acute promyelocytic leukemia-like disorder with a chronic course. 244
PEGylated siRNA lipoplexes for silencing of BLIMP-1 in Primary Effusion Lymphoma: In vitro evidences of antitumoral activity 243
Changes in the immune responses against human herpesvirus-8 in the disease course of posttransplant Kaposi sarcoma 238
Organising pneumonia mimicking invasive fungal disease in patients with leukaemia. 237
Complessazione di SiRNA anti Blimp-1/PRDM con liposomi cationici: caratterizzazione chimico-fisica e validazione in vitro su cellule di PEL 236
The bone marrow represents an enrichment site of specific T lymphocytes against filamentous fungi 231
Cidofovir-loaded liposomes: an intro-study using BCBL-1 cell line as a model for primary effusion lymphoma 227
Effectiveness of originator (Neupogen) and biosimilar (Zarzio) filgrastim in autologous peripheral blood stem cell mobilization in adults with acute myeloid leukemia: a single-center retrospective study 226
Atraumatic splenic rupture in patients with myelodysplastic syndromes: Report of a case occurred during treatment with 5-azacitidine and review of the literature. 223
An unusual case of B-ALL occurring in a patient with acute promyelocytic leukemia in remission after two hematopoietic SCTs: whose are the leukemic cells? 219
Emergence of BCR-ABL-specific cytotoxic T cells in the bone marrow of patients with Ph+ acute lymphoblastic leukemia during long-term Imatinib mesylate treatment. 219
Mucorales-specific T cells in patients with hematologic malignancies 218
Characterization and dynamics of specific T cells against nucleophosmin-1 (NPM1)-mutated peptides in patients with NPM1-mutated acute myeloid leukemia 214
BCR-ABL-specific cytotoxic T cells in the bone marrow of patients with Ph(+) acute lymphoblastic leukemia during second-generation tyrosine-kinase inhibitor therapy. 213
Anticancer drug-loaded quantum dots engineered polymeric nanoparticles: Diagnosis/therapy combined approach 213
May the indirect effects of CIHHV-6 in transplant patients be exerted through the reactivation of the viral replicative machinery? 213
Human Herpesvirus 8 (HHV8) Infection and Related Diseases in Italian Transplant Cohorts. 212
Antineoplastic effects of liposomal siRNA treatment targeting BLIMP1/PRDM1 in primary effusion lymphoma 212
Changes in T-Cell Responses Against Human Herpesvirus-8 Correlate with the Disease Course of Iatrogenic Kaposi's Sarcoma in a Patient with Undifferentiated Arthritis 211
B cells and herpesviruses: a model of lymphoproliferation 209
Epstein-Barr virusassociated pneumonia in an adult patient with severe aplastic anaemia: resolutionafter the transient withdrawal of cyclosporine. 205
Circulating functional T cells specific to human herpes virus 6 (HHV6) antigens in individuals with chromosomally integrated HHV6 205
Nutlin-3 loaded nanocarriers: Preparation, characterization and in vitro antineoplastic effect against primary effusion lymphoma 202
Chronic and recurrent benign lymphadenopathy without constitutional symptoms associated with human herpesvirus-6B reactivation 200
Treatment of herpesvirus associated primary effusion lymphoma with intracavity cidofovir 195
Parvoviruses in blood donors and transplant patients, Italy 194
Assessment of aspergillus-specific T cells for diagnosis of invasive aspergillosis in a leukemic child with liver lesions mimicking hepatosplenic candidiasis 194
HHV-6 and atypical lymphoproliferative disorders: are only qualitative molecular examinations sufficient to support a pathogenetic role? 194
Isolated extramedullary relapse after autologous bone marrow transplantation for acute myeloid leukemia: Case report and review of the literature 193
Successful Treatment of KSHV Inflammatory Cytokine Syndrome (KICS) after Kidney-Liver Transplant: Correlations with HHV8 miRNome and Specific T-Cell Response 192
How I treat HHV8/KSHV-related diseases in posttransplant patients. 190
A t(11;20)(p15;q11) may identify a subset of nontherapy-related acute myelocytic leukemia 189
Multicenter Prospective Study for Laboratory Diagnosis of HHV8 Infection in Solid Organ Donors and Transplant Recipients and Evaluation of the Clinical Impact After Transplantation 189
Indirect Antitumor Effects of Mammalian Target of Rapamycin Inhibitors Against Kaposi Sarcoma in Transplant Patients 187
Novel polymeric/lipidic hybrid systems (PLHs) for effective Cidofovir delivery: preparation, characterization and comparative in vitro study with polymeric particles and liposomes 187
All-trans retinoic acid (ATRA) in non-promyelocytic acute myeloid leukemia (AML): results of combination of ATRA with low-dose Ara-C in three elderly patients with NPM1-mutated AML unfit for intensive chemotherapy and review of the literature 187
Thrombotic complications associated with thalidomide in multiple myeloma: an old problem with new questions and quandaries in decision-making 185
Common vascular endothelial growth factor variants and risk for posttransplant Kaposi sarcoma. 184
Mucorles-specific T cells emerge in the course of invasive mucormucosis and may be used as a surrogate diagnostic marker in high-risk patients 184
Severe pancytopenia and hemophagocytosis after HHV-8 primary infection in a renal transplant patient successfully treated with foscarnet 183
Nanosistemi lipidici targettizzati per il direzionamento di siRNA con attività antineoplastica al linfoma primitivo delle cavità sierose (PEL) 182
Long-term molecular remission with persistence of BCR-ABL1-specific cytotoxic T cells following imatinib withdrawal in an elderly patient with Philadelphia-positive ALL 181
Interferon-alpha may restore sensitivity to tyrosine-kinase inhibitors in Philadelphia chromosome positive acute lymphoblastic leukaemia with F317L mutation 176
Monocyte Distribution Width (MDW) as novel inflammatory marker with prognostic significance in COVID-19 patients 176
Late occurrence of hepatic veno-occlusive disease following gemtuzumab ozogamicin: successful treatment with defibrotide 175
Chronic/relapsing lymphadenopathy associated with HHV-6B infection: a new benign clinico-pathologic entity occurring in immunocompetent individuals 174
LIPOPLEXES PER LA VEICOLAZIONE ED IL DIREZIONAMENTO DI siRNA AL PEL: VALUTAZIONE DELL’EFFICIENZA DI TRATTAMENTO CON SISTEMI LIPIDICI STABILIZZATI 173
Veicolazione liposomiale del cidofovir nel trattamento del PEL (Primary Effusion Lynphoma) 173
Myocardial ischemia in a patient with acute lymphoblastic leukemia during L-asparaginase therapy 171
Cardiac involvement in malignancies. Case 2. Right ventricular lesion as presenting feature of acute promyelocytic leukemia 171
Differences in Kaposi sarcoma-associated herpesvirus-specific and herpesvirus-non-specific immune responses in classic Kaposi sarcoma cases and matched controls in Sicily. 169
Human herpesvirus 8-associated diseases in solid-organ transplantation: importance of viral transmission from the donor 166
Prevalence of Human Herpesvirus-6 Chromosomal Integration (CIHHV-6) in Italian Solid Organ and Allogeneic Stem Cell Transplant Patients 161
Is it now the time to update treatment protocols for lymphomas with new anti-virus systems? 161
May the correlation between Kit-D816 mutation and AML1-ETO level change the use of prognostic factors in t(8;21) AML? 157
Herpes simplex virus pneumonia during standard induction chemotherapy for acute leukemia: case report and review of literature. 155
Immunoliposomal systems targeting the primary effusion lymphoma (PEL): in vitro study 153
Suppressive effect of human herpesvirus-8/Kaposi sarcoma-associated herpesvirus on in vitro colony formation of hematopoietic progenitor cells 153
Identification and characterization of Aspergillus-specific immune responses to diagnose invasive aspergillosis in high risk patients: a multicenter study 152
Trends in immune cell function assay and donor-specific HLA antibodies in kidney transplantation: A 3-year prospective study 150
siRNA-BASED THERAPEUTICS: DELIVERY AND TARGETING TO PEL TUMOR BY USING CATIONIC LIPOSOMES 150
Tumor-targeted immunoliposomal nanosystems to deliver either Cidofovir or Antineoplastic SiRNA against Primary Effusion Lymphoma (PEL) 149
Pneumonia in acute leukaemia:blossoming culprits 148
β-HHVs and HHV-8 in Lymphoproliferative Disorders. 135
Cytomegalovirus and ClostridiumDifficile co-infection in severe ulcero-hemorrhagic colitis during inductionchemotherapy for acute lymphoblastic leukemia 130
Efficacy of imatinib mesylate as maintenance therapy in adults with acute lymphoblastic leukemia in first complete remission 129
KNOCK-DOWN DI BLIMP1/PRDM1 IN CELLULE PEL MEDIANTE siRNA; OTTIMIZZAZIONE DEL SISTEMA DI TRANSFEZIONE E STUDI IN VITRO 122
Immunoliposome for the delivery of drugs and SiRNA for the treatment of cancer 115
Successful generation of p190-BCR ABL-specific T-cell lines for prophylaxis/treatment of minimal residual disease in HSCT recipients with Ph+ acute lymphoblastic leukaemia 114
Formulazione di siRNA anti blimp-1/PRDM in liposomi cationici: caratterizzazione chimico-fisica e validazione in vitro su cellule di LINFOMA EFFUSIVO PRIMARIO (pel) 108
Immunoliposomes to target the Primary Effusion Lymphoma (PEL): in vitro study 102
Development and characterization of immunoliposomes for Cidofovir and SiRNA delivery: a new strategy for the treatment of Primary Effusion Lymphoma 100
Formulation and characterization of new Polymeric/Lipidic Hybrid systems for cidofovir delivery 100
Immunoliposomes for the delivery of SiRNA and chemioterapeutic agent to primary effusion lymphoma 99
Immunoliposomes for the delivery of SiRNA and chemioterapeutic agent to primary effusion lymphoma 99
Immunological and inflammatory features of Kaposi's sarcoma and other Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8-associated neoplasias. 83
Linking COVID-19, monocyte activation and sepsis: MDW, a novel biomarker from cytometry 80
Preclinical Validation of an Advanced Therapy Medicinal Product Based on Cytotoxic T Lymphocytes Specific for Mutated Nucleophosmin (NPM1mut) for the Treatment of NPM1mut-Acute Myeloid Leukemia 44
Identification and validation of diagnostic cut-offs of the ELISpot assay for the diagnosis of invasive aspergillosis in high-risk patients 27
From gating to computational flow cytometry: Exploiting artificial intelligence for MRD diagnostics 25
Totale 15.306
Salva come PNG Salva come JPEG
Categoria #
all - tutte 56.917
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 56.917
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.230 0 0 0 0 0 460 621 453 302 115 140 139
2020/20212.237 212 125 145 251 234 133 154 276 114 318 141 134
2021/20221.747 67 228 221 98 29 63 104 92 175 135 338 197
2022/20231.999 281 248 142 187 281 244 48 184 174 18 105 87
2023/20241.295 41 69 98 96 271 146 137 207 23 24 60 123
2024/20251.799 155 49 76 279 701 539 0 0 0 0 0 0
Totale 15.306